Vaccine Contract Manufacturing Market Trends, Capacity, Production, Analysis And Forecast 2025
Global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, A vaccine provides active acquired immunity to a disease. The demand for vaccine contract manufacturing is increasing in the market.”
Global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, A vaccine provides active acquired immunity to a disease. The demand for vaccine contract manufacturing is increasing in the market.”
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> <strong>Market</strong> <strong>Trends</strong>, <strong>Capacity</strong>,<br />
<strong>Production</strong>, <strong>Analysis</strong> <strong>And</strong> <strong>Forecast</strong> <strong>2025</strong><br />
“Global <strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> <strong>Market</strong> size is expected to reach USD<br />
4.0 billion by <strong>2025</strong>, A vaccine provides active acquired immunity to a disease.<br />
The demand for vaccine contract manufacturing is increasing in the market.”<br />
Global <strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> <strong>Market</strong> size is expected to reach USD 4.0 billion by <strong>2025</strong>, A vaccine<br />
provides active acquired immunity to a disease. The demand for vaccine contract manufacturing is increasing in<br />
the market. <strong>Vaccine</strong> manufacturing is a complex process, in which effectivity, safety and consistency are the<br />
most important part for the manufacturers. It offers many services such as production process, cell line<br />
development, construction & operation of manufacturing product, process optimization, fermentation and<br />
analytical characterization, which fuels the market growth in the coming years. The vaccine contract<br />
manufacturing market registering a CAGR of 9.3% in the upcoming period as the scope, product types, and its<br />
applications are increasing across the globe.<br />
<strong>Vaccine</strong> contract services offer cost-saving benefits to their clients. Also, they help to save time in operations &<br />
management of a research and production facility. The growing demand for vaccine development from the<br />
private sector as well as governments in developing and industrialized countries is expected to witness<br />
significant growth of the market in the coming years.<br />
In the market, various types of vaccines are available such as inactivated vaccines, attenuated vaccines, toxoidbased<br />
vaccines, subunit-based vaccines, DNA-based vaccines, recombinant vector vaccines, synthetic vaccines<br />
and others. The “attenuated vaccines” is expected to hold the large market share in the upcoming period due<br />
to their ability to elicit strong and antibody responses. These vaccines offer lifetime immunities with just one or<br />
two doses. Moreover, proper handling conditions, especially with respect to storage and maintenance will<br />
continue to drive the segment in the coming years.<br />
Request Sample Copy of this <strong>Market</strong> Research @<br />
https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market/request-sample
In addition, in the market some single as well as combination vaccine are available. The single vaccine such as<br />
influenza virus, ebola virus, chickenpox, smallpox, polio, tetanus, tuberculosis and others could be explored in<br />
vaccine contract manufacturing industry. The factors that play an important role in the growth of market include<br />
increasing demand, growing population, increasing urbanization & industrialization, growing pharmaceutical<br />
industry, increase in the number of countries demanding the introduction of vaccines, stringent government<br />
rules & regulations and increasing awareness about vaccination & its benefits in developing countries.<br />
Moreover, increasing prevalence of various bacterial and viral infections is a main factor drive the growth of the<br />
vaccine contract manufacturing market in the next couple of years.<br />
However, high cost of vaccination, regulatory challenges and patent expiration in recent times are negatively<br />
impacting the growth of vaccine contract manufacturing industry. The market is widely analyzed based on<br />
different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and<br />
others. The market is categorized based on vaccine type, product type, workflow, application and geography.<br />
The market is classified into workflow such as downstream and upstream. The “downstream” segment is further<br />
segregated into fill & finish operations, packaging and analytical & QC studies whereas the segment “upstream”<br />
is segmented into mammalian expression systems, yeast expression systems, bacterial expression systems,<br />
baculovirus/insect expression systems and others. <strong>Vaccine</strong> production requires skilled personnel for<br />
downstream as well as upstream processing. The “downstream” segment is expected to witness significant<br />
growth in the coming years owing to the robust demand for downstream processing and sophisticated<br />
equipment for efficient product recovery.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market<br />
North America is accounting large market share in the years to come owing to widespread manufacturing of<br />
vaccines in this region, coupled with growing presence of large number of biopharmaceutical facilities. State<br />
and the other laws pertaining to development of vaccines & other biologics, particularly in Canada and U.S. are<br />
expected to boost the market growth in this region. On the other hand, Asia Pacific is projected to grow at a<br />
higher CAGR in the next couple of years due to growing population, improving infrastructure in several<br />
developing countries, and growing pharmaceutical industry.<br />
The key players contributing to the robust development of the vaccine contract manufacturing market include<br />
Lonza, Paragon Bioservices Inc., Ajinomoto Althea Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Merck<br />
KGaA, Cytovance Biologics, Catalent Inc., IDT Biologika GmbH, Albany Molecular Research Inc., PRA Health<br />
Sciences, ICON plc., Pharmaceutical Product Development, LLC, and Cobra Bio. The major market players are<br />
focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions,<br />
and joint ventures are the need of the hour.
<strong>Market</strong> Segment:<br />
<strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> <strong>Vaccine</strong> Type Outlook (Revenue, USD Million, 2014 - <strong>2025</strong>)<br />
• Attenuated <strong>Vaccine</strong><br />
• Inactivated <strong>Vaccine</strong><br />
• Subunit <strong>Vaccine</strong>s<br />
• Toxoid <strong>Vaccine</strong>s<br />
• DNA <strong>Vaccine</strong>s<br />
<strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> Workflow Outlook (Revenue, USD Million, 2014 - <strong>2025</strong>)<br />
• Downstream<br />
• Fill & Finish Operations<br />
• Analytical & QC studies<br />
• Packaging<br />
• Upstream<br />
• Mammalian Expression Systems<br />
• Bacterial Expression Systems<br />
• Yeast Expression Systems<br />
• Baculovirus/Insect Expression Systems<br />
• Others<br />
<strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> Application Outlook (Revenue, USD Million, 2014 - <strong>2025</strong>)<br />
• Human Use<br />
• Veterinary<br />
<strong>Vaccine</strong> <strong>Contract</strong> <strong>Manufacturing</strong> Regional Outlook (Revenue, USD Million, 2014 - <strong>2025</strong>)<br />
• North America<br />
• Asia Pacific<br />
• Latin America<br />
• Middle East & Africa<br />
See More Reports of this Category by Million Insights @<br />
https://www.millioninsights.com/industry/pharmaceuticals
Get in touch<br />
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our<br />
representatives strive to understand diverse client requirements and cater to the same with the<br />
most innovative and functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016<br />
India<br />
Phone: 91-20-65300184